Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Viaskin HDM
- Development stage
- Preclinical
- Lead developer
- DBV Technologies
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Vaccines & Immunotherapeutics
- Administration
- Epicutaneous, Transdermal
01
Overview
Viaskin HDM is an investigational epicutaneous immunotherapy patch developed for the treatment of house dust mite (HDM) allergy. The therapy uses a non-invasive skin patch to deliver microgram amounts of house dust mite allergen proteins directly to the immune system through intact skin, aiming to desensitize allergic individuals by leveraging the skin’s immune tolerizing properties. This approach, known as epicutaneous immunotherapy (EPIT), seeks to re-educate the immune system and reduce allergic responses over time. The technology is being developed by DBV Technologies, which has also advanced similar patches for peanut and milk allergies[3]. Clinical development has focused on pediatric populations with dust mite-induced allergic conditions.
- Brand names
- Viaskin HDM
- Other names
- Viaskin HDM
02
Targets
House dust mite allergen proteins
Beyond the preview
Go deeper on Viaskin HDM.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Viaskin HDM.